Clinical Trial Update: Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

View source ↗

Summary

Clinical trial update reporting a cost-effectiveness study of epoetin alfa and darbepoetin alfa in adult cancer patients with anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Neoplasms

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Janssen-Cilag B.V. | Conditions: Anemia, Neoplasms | Status: COMPLETED